Business Segments · Other (income) expense, net
MEDTECH — Other (income) expense, net
Johnson & Johnson MEDTECH — Other (income) expense, net decreased by 90.6% to $76.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 226.7%, from -$60.00M to $76.00M. Over 3 years (FY 2022 to FY 2025), MEDTECH — Other (income) expense, net shows an upward trend with a 19.3% CAGR.
Analysis
StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026Apr 22, 2026
Rolls up toOther Income (Expense)
How to read this metric
Large, unexpected values may indicate one-time events or non-recurring financial impacts.
Detailed definition
Includes non-operating income or expenses specific to the MedTech segment, such as gains or losses from asset sales, lit...
Peer comparison
Standard 'Other' line item found in segment reporting across most industries.
Metric ID:
jnj_segment_medtech_other_income_expense_netHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.25M | $138.25M | $138.25M | $138.25M | -$147.25M | -$147.25M | -$147.25M | -$147.25M | -$47.00M | $231.00M | -$11.00M | $84.00M | -$60.00M | $190.00M | $2.00M | $806.00M | $76.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -206.5% | +0.0% | +0.0% | +0.0% | +68.1% | +591.5% | -104.8% | +863.6% | -171.4% | +416.7% | -98.9% | >999% | -90.6% |
| YoY Change | — | — | — | — | -206.5% | -206.5% | -206.5% | -206.5% | +68.1% | +256.9% | +92.5% | +157.0% | -27.7% | -17.7% | +118.2% | +859.5% | +226.7% |
Range-$147.25M – $806.00M
CAGR-13.9%
Avg YoY Growth+69.8%
Median YoY Growth+68.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — other (income) expense, net?
- Johnson & Johnson (JNJ) reported medtech — other (income) expense, net of $76.00M in Q1 2026.
- How has Johnson & Johnson's medtech — other (income) expense, net changed year-over-year?
- Johnson & Johnson's medtech — other (income) expense, net increased by 226.7% year-over-year, from -$60.00M to $76.00M.
- What is the long-term trend for Johnson & Johnson's medtech — other (income) expense, net?
- Over 3 years (2022 to 2025), Johnson & Johnson's medtech — other (income) expense, net has grown at a 19.3% compound annual growth rate (CAGR), from $553.00M to $938.00M.
- What does medtech — other (income) expense, net mean?
- Miscellaneous income or expenses not related to the core business operations of the MedTech segment.